Chronic functional constipation. Other constipation
Conditions
Interventions
Intervention 1: Intervention group: Intervention group 1: In Pidrolax group, the child is given 0.7 g / kg body weight (Sepidaj Pharmaceutical Company, Iran) orally in the morning fasting. Interventio
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Inclusion criteria
Inclusion criteria: All children with chronic constipation for at least 6 months aged 2-6 years referred to the pediatric clinic of Amirkabir Hospital Parental consent Do not have any disease other than constipation Absence of any psychiatric disorders in the child or parents No maintenance in welfare or other places than family Not to receive constipation treatment for 2 weeks before inclusion in the study Not being a single parent Absence of IBS according to ROME IV criteria Absence of mental retardation or metabolic disease (such as hypothyroidism), Hirschsprung or spinal anomalies or anorectal pathology Absence of gastrointestinal surgery Not to receive medical treatment affecting GI motility such as cisapride, motilium, erythromycin, loperamide
Exclusion criteria
Exclusion criteria: Lack of cooperation of parent or child Incidence of drug side effects and severe diarrhea Allergy to drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary consequence : Number of defecation per week. Timepoint: Before starting treatment, The first week after starting treatment, Then every 2 weeks until two months later. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary consequence : Nausea. Timepoint: Before starting treatment, The first week after starting treatment, Then every 2 weeks until two months later. Method of measurement: questionnaire.;Secondary consequence : Stool consistency. Timepoint: Before starting treatment, The first week after starting treatment, Then every 2 weeks until two months later. Method of measurement: questionnaire.;Secondary consequence : Number of abdominal pains per week. Timepoint: Before starting treatment, The first week after starting treatment, Then every 2 weeks until two months later. Method of measurement: questionnaire.;Secondary consequence : Number of painful bowel movements per week. Timepoint: Before starting treatment, The first week after starting treatment, Then every 2 weeks until two months later. Method of measurement: questionnaire.;Secondary consequence : Anorexia. Timepoint: Before starting treatment, The first week after starting treatment, Then every 2 weeks until two months later. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mojtaba Hashemi
Arak University of Medical Sciences
Outcome results
None listed